Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet on the Evolution of Body Fat

NCT ID: NCT01464073

Last Updated: 2015-07-29

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 137 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2011-11-30
• Study Completion Date: 2012-09-30

Brief Summary

The purpose of this study is to evaluate the efficacy of 3 of physical exercise training programs, with a supplementation in fruits and vegetables, on body composition. 126 women will be randomized into 3 groups (42 subjects per group). The first program will be conducted at a relatively low intensity of effort, corresponding to the maximum rate of lipid oxidation (LIPOXmax)measured by indirect calorimetry. The second program will be at 60% of VO2peak and the third program will be prescribed according to the Good Practices physical Guidelines (30 minutes per day at a moderate intensity). All subjects will receive a free supplement of 5 fruits and vegetables per day during all the intervention. The intervention will last 5 months in total.

Detailed Description

Background: in Reunion Island, in 2000 the REDIA study showed a prevalence of type 2 diabetes among 30-69 years old people above 17%, a prevalence of obesity among women of 20% and 10% for men. According to the literature upon preventive strategies and/or treatment of metabolic diseases, regular physical activity associated with a balanced diet and an intake of fruits and vegetables, can reduce body fat mass and prevent the complications related to obesity. These complications are partly related to the inflammatory and oxidative stress that accompanies obesity. A diet rich in fruits and vegetables, may improve the inflammatory and oxidative status. However there is no consensus on the intensity of regular physical activity in the practices of prevention and care. These parameters are generally not individualized. International recommendations cover a wide range of exercise intensity (between 40% and 60% of maximal oxygen uptake). The research group of Jacques Mercier (CERAMM Lapeyronie-CHU Montpellier) showed the benefit of the training conducted at a relatively low intensity of effort, corresponding to the maximum rate of lipid oxidation (LIPOXmax), and its effects on the fat mass, the insulin sensitivity and the muscle metabolism, in overweight or obese people.

Main objective: to study the effects of three programs of rehabilitation training associated with a diet supplemented with fruits and vegetables, on reducing body fat in overweight or obese people.

Secondary objectives: to study the effects on the oxidative stress and the inflammatory status, compare the efficacy of these 3 programs of physical training on body composition modifications, insulin sensitivity, lipid utilization during exercise and quality of life, describe feasibility in population (compliance, motivation).

Abstract: according to data from the literature, a balanced diet combined with moderate exercise helps to fight against biological complications related to obesity and to reduce the incidence of type 2 diabetes by promoting fat loss. But there is no consensus on the intensity of physical activity prescribed. Have been shown the benefits of training performed at an individualized intensity of effort, relatively low, corresponding to the maximum rate of lipid oxidation measured by indirect calorimeter (LIPOXmax) on fat loss, sensitivity to insulin and muscle metabolism in obese or diabetic patients. However, an individualized LIPOXmax exercise training has not yet been compared to a standardized training conventionally used in the treatment of obese subjects. Furthermore, no study has yet evaluated the impact of LIPOXmax training on inflammatory and antioxidant status among overweight and obese patients. We propose to compare among overweight or obese patients, the effects of an individualized training at an intensity corresponding to LIPOXmax, the effects of a standardized training to 60% of VO2max, and the effects of a moderate and regular physical activity prescribed according to guidelines of Good Medical Practices.

At M0 participants will have anthropometric and functional examinations and laboratory tests, and will follow nutritional education sessions. They will be then randomized into 3 arms: arm 1 LIPOXmax physical activity, arm 2 60% VO2max physical activity, arm 3 physical activity according to guidelines of Good Medical Practices. Participants of the arms 1 and 2 will practice under the control of a sports instructor; participants of the arm 3 will be regularly monitored by telephone. The procedure will last 5 months. At M3 and M5 anthropometric and biological examinations will be replicated and participants will answer to questionnaires on quality of life and experience of physical activity during and after the intervention.

Primary outcome: body fat mass reduction, in kilograms and in % of total weight.

Secondary outcomes: improvement of biological parameters (markers of inflammation and antioxidant status, blood glucose, HbA1c, insulin, cholesterol, HDL / LDL, triglycerides); improvement in body composition (weight, BMI, waist circumference, hip circumference, muscle mass), and in lipid utilization during exercise; improvement of the quality of life; demonstration of the feasibility in population (adherence, compliance).

Study design: controlled, randomized, of superiority, not blind trial in 126 people divided into three arms of 42 people per arm: arm 1 LIPOXmax intensity of effort, arm 2 60% of VO2max intensity of effort, arm 3 intensity of effort according to the Guidelines of Good Medical Practices.

Intervention: the 126 subjects will undergo the following exams: weight, height, waist and hip circumference, blood pressure, body fat measurement by impedancemetry and biphotonic absorptiometry, maximal cardiopulmonary exercise and effort metabolic test (by indirect calorimeter to determine the LIPOXmax and the crossing points of the substrates), laboratory tests (blood glucose, HbA1c, insulin, cholesterol total, HDL, LDL, triglycerides, CRP, albumin, creatinine, urinary parameters, antioxidant status, inflammatory markers); questionnaires about medical history and sociodemographic data; food survey (frequency questionnaire, quantization by photos), questionnaires on physical activity (Baecke amended), quality of life (SF-36), experience of physical activity. All the participants will have an initial nutritional education session and will receive a free supplement of 5 fruits and vegetables per day during all the intervention, and random urine assays will be performed to monitor the consumption of fruits and vegetables. Participants will be randomized into three arms. Arm 1: LIPOXmax arm. Subjects will perform a physical activity 4x1 hour per week at the optimal intensity for fat oxidation (LIPOXmax) measured by indirect calorimeter. Arm 2: physical activity standard arm (60% of VO2max measured by cardio respiratory exercise test). Subjects will realize 4 sessions per week and duration of sessions will be adjusted so that arms 1 and 2 have the same total energy expenditure by session. Arm 3: control arm. The subjects initially receive the recommendations of good medical practice for physical activity (achieving at least 3h30min per week of "moderate" exercise). The intervention will last 5 months in total. For arms 1 and 2: physical activity on ergo meter bicycle controlled by a sports trainer, with the goal of gradual empowerment. For arm 3: self-directed activities with regular telephone follow-up, holding of a book on physical activities and use of a pedometer during walking sessions. Indemnization: all the participants will receive a monthly allowance for the constraints due to their participation.

Number of subjects: to highlight a difference in average change of 1.5 kg fat mass, with a standard deviation of 2.0 kg, a first species risk of 1.67% (5% / 3), a power of 80%, it is necessary to include 38 subjects. In such circumstances it will be possible to demonstrate a theoretical minimum significant difference between arms of: - 2.3% on changes at 5 month of average percentage of body fat (SD = 3%) and - 3.8 kg on changes at 5 months of average weight (SD = 5 kg). Due to missing data (dropouts, lost) rate estimated at 10%, it is planned to include 42 subjects per arm, or 126 in total.

Statistical analysis: single analysis in intention to treat (arms assigned by the randomization). Overall first species risk = 5%. Bilateral formulation of statistical tests. Statistical methods used: bivariate analysis (one factor ANOVA, Pearson Chi2 test or Fisher test), multivariate analysis (ANCOVA, logistic regression). Taking into account the longitudinal data (M0-M3-M5) with generalized estimating equations (GEE). Graphic representation of the evolutions over the study.

Conditions

Obesity

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: NONE

Study Groups

arm 3 : Good Medical Practices

physical exercise at home monitored by telephone (achieving a minimum of 30 minutes per day)

Group Type: ACTIVE_COMPARATOR

Good Medical Practices

Intervention Type: BEHAVIORAL

Arm 3: The subjects initially receive the recommendations of good medical practice for physical activity (achieving at least 30min per day of "moderate" exercise).

supplementation in fruits and vegetables

Intervention Type: DIETARY_SUPPLEMENT

all groups will be supplemented in fruits and vegetables (5 per day) during all the study

arm 2 : 60% VO2peak

physical exercise at the intensity of 60% of VO2 peak. 4 times a week. duration will be adjusted for arm 1 and arm 2 have the same total energy expenditure by session.

Group Type: ACTIVE_COMPARATOR

60% VO2peak

Intervention Type: BEHAVIORAL

Arm 2: physical activity standard arm (60% of VO2max measured by cardio respiratory exercise test). Subjects will realize 4 sessions per week and duration of sessions will be adjusted so that arms 1 and 2 have the same total energy expenditure by session.

supplementation in fruits and vegetables

Intervention Type: DIETARY_SUPPLEMENT

all groups will be supplemented in fruits and vegetables (5 per day) during all the study

arm 1 : LIPOXmax

physical exercise at the LIPOXmax intensity during 60 minutes. 4 times a week

Group Type: EXPERIMENTAL

LIPOXmax

Intervention Type: BEHAVIORAL

Arm 1: LIPOXmax arm. Subjects will perform a physical activity 4x1 hour per week at the optimal intensity for fat oxidation (LIPOXmax) measured by indirect calorimeter.

supplementation in fruits and vegetables

Intervention Type: DIETARY_SUPPLEMENT

all groups will be supplemented in fruits and vegetables (5 per day) during all the study

Interventions

LIPOXmax

Arm 1: LIPOXmax arm. Subjects will perform a physical activity 4x1 hour per week at the optimal intensity for fat oxidation (LIPOXmax) measured by indirect calorimeter.

Intervention Type: BEHAVIORAL

60% VO2peak

Arm 2: physical activity standard arm (60% of VO2max measured by cardio respiratory exercise test). Subjects will realize 4 sessions per week and duration of sessions will be adjusted so that arms 1 and 2 have the same total energy expenditure by session.

Intervention Type: BEHAVIORAL

Good Medical Practices

Arm 3: The subjects initially receive the recommendations of good medical practice for physical activity (achieving at least 30min per day of "moderate" exercise).

Intervention Type: BEHAVIORAL

supplementation in fruits and vegetables

all groups will be supplemented in fruits and vegetables (5 per day) during all the study

Intervention Type: DIETARY_SUPPLEMENT

Other Intervention Names

FAT oxydation rate; FATmax; FATOXmax; physical exercise; exercise training; physical exercise; exercise training; diet; dietary supplement

Eligibility Criteria

Inclusion Criteria

• women
• 20-40 years old
• 27 ≤ BMI ≤40 kg / m²
• sedentary
• considered clinically stable
• able to rehabilitation training
• having signed an informed consent
• without professional activity

Exclusion Criteria

• blood glucose ≥ 1.26 g / l
• HbA1c ≥ 6.5%
• severe hypertension (SBP ≥ 180 mmHg and / or DBP ≥ 110 mmHg)
• hypertension (≥140/90 mmHg) untreated or treated by beta blocker or calcium blocker
• absolute and relative contraindication to the maximal exercise test (ACC / AHA 2002) and / or physical training
• inability to achieve the maximum exercise test and / or the metabolic exercise test by indirect calorimeter
• uncompensated cardiovascular and / or respiratory disease revealed by exercise test
• pacemaker or defibrillator
• recent cardiovascular events (heart failure, treated by positive inotropic drugs, angioplasty within the last 10 days, cardiac surgery within the last 3 months, valvular disease requiring surgical correction, evolving myopericarditis, severe ventricular arrhythmias non stabilized under treatment)
• known and documented myopathy
• cancer
• acute and chronic inflammatory disease
• end stage renal disease
• digestive system operation
• treated by corticoids, thyroid hormone, antidepressant or neuroleptics
• pregnancy
• mental deficiency that prevents the understanding of informed consent and protocol
• participation to another research protocol
• attendance in the previous month to a program of rehabilitation training or a diet
• associated evolutionary disease causing significant impairment of general condition.

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 40 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Centre Hospitalier Universitaire de la Réunion

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Centre Hospitalier Universitaire

Saint-Pierre, Île de La Réunion, France

Countries

France

References

Besnier F, Lenclume V, Gerardin P, Fianu A, Martinez J, Naty N, Porcherat S, Boussaid K, Schneebeli S, Jarlet E, Hatia S, Dalleau G, Verkindt C, Brun JF, Gonthier MP, Favier F. Individualized Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in Overweight or Obese Women: The LIPOXmax-Reunion Randomized Controlled Trial. PLoS One. 2015 Nov 10;10(11):e0139246. doi: 10.1371/journal.pone.0139246. eCollection 2015.

Reference Type: DERIVED

PMID: 26555595 (View on PubMed)

Other Identifiers

LIPOXmax

Identifier Type: -

Identifier Source: org_study_id